1
|
Lupia A, Soroka S, Beatty A. What does Congress want from the National Science Foundation? A content analysis of remarks from 1995 to 2018. Sci Adv 2020; 6:eaaz6300. [PMID: 32851156 PMCID: PMC7428327 DOI: 10.1126/sciadv.aaz6300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/25/2019] [Accepted: 07/02/2020] [Indexed: 06/11/2023]
Abstract
The U.S. Congress writes the legislation that funds the National Science Foundation (NSF). Researchers who seek NSF support may benefit by understanding how Congress views the agency. To this end, we use text analysis to examine every statement in the Congressional Record made by any member of Congress about the NSF over a 22-year period. While we find broad bipartisan support for the NSF, there are notable changes over time. Republicans have become more likely to express concerns about accountability in how the NSF spends its funds. Democrats are more likely to focus on how NSF-funded activities affect education, technology, and students. We use these findings to articulate how researchers and scientific organizations can more effectively conduct transformative science that corresponds to long-term and broadly held Congressional priorities.
Collapse
Affiliation(s)
- A. Lupia
- Department of Political Science, University of Michigan, Ann Arbor, MI, USA
| | - S. Soroka
- Department of Political Science, University of Michigan, Ann Arbor, MI, USA
- Department of Communication and Media, University of Michigan, Ann Arbor, MI, USA
| | - A. Beatty
- Gerald R. Ford School of Public Policy, University of Michigan, Ann Arbor, MI, USA
| |
Collapse
|
2
|
Gaudio E, Spriano F, Tarantelli C, Guala M, Riveiro E, Golino G, Lupia A, Costa G, Rocca R, Cascione L, Jenni S, Tsai Y, Bornhauser B, Alcaro S, Paduano F, Trapasso F, Zucca E, Stathis A, Pazzi N, Cavalli F, Bertoni F. EG-011 IS A NOVEL SMALL MOLECULE WITH IN VITRO
AND IN VIVO
ANTI-TUMOR ACTIVITY AGAINST LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.197_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- E. Gaudio
- Università della Svizzera Italiana; Institute of Oncology Research; Bellinzona Switzerland
| | - F. Spriano
- Università della Svizzera Italiana; Institute of Oncology Research; Bellinzona Switzerland
| | - C. Tarantelli
- Università della Svizzera Italiana; Institute of Oncology Research; Bellinzona Switzerland
| | | | - E. Riveiro
- Early Drug Development Group; ris France
| | - G. Golino
- University “Magna Graecia” of Catanzaro; Catanzaro Italy
| | - A. Lupia
- University “Magna Graecia” of Catanzaro; Catanzaro Italy
| | - G. Costa
- University “Magna Graecia” of Catanzaro; Catanzaro Italy
| | - R. Rocca
- University “Magna Graecia” of Catanzaro; Catanzaro Italy
| | - L. Cascione
- Università della Svizzera Italiana; Institute of Oncology Research; Bellinzona Switzerland
| | - S. Jenni
- Children's Hospital Zurich; Zurich Switzerland
| | - Y. Tsai
- Children's Hospital Zurich; Zurich Switzerland
| | | | - S. Alcaro
- University “Magna Graecia” of Catanzaro; Catanzaro Italy
| | - F. Paduano
- University “Magna Graecia” of Catanzaro; Catanzaro Italy
| | - F. Trapasso
- University “Magna Graecia” of Catanzaro; Catanzaro Italy
| | - E. Zucca
- Oncology Institute of Southern Switzerland; Bellinzona Switzerland
| | - A. Stathis
- Oncology Institute of Southern Switzerland; Bellinzona Switzerland
| | | | - F. Cavalli
- Oncology Institute of Southern Switzerland; Bellinzona Switzerland
| | - F. Bertoni
- Università della Svizzera Italiana; Institute of Oncology Research; Bellinzona Switzerland
| |
Collapse
|
3
|
Jasny BR, Wigginton N, McNutt M, Bubela T, Buck S, Cook-Deegan R, Gardner T, Hanson B, Hustad C, Kiermer V, Lazer D, Lupia A, Manrai A, McConnell L, Noonan K, Phimister E, Simon B, Strandburg K, Summers Z, Watts D. Fostering reproducibility in industry-academia research. Science 2017; 357:759-761. [PMID: 28839064 DOI: 10.1126/science.aan4906] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Affiliation(s)
| | - N Wigginton
- University of Michigan, Ann Arbor, MI 48109, USA
| | - M McNutt
- National Academy of Sciences, Washington, DC 20001, USA.
| | - T Bubela
- Faculty of Health Sciences, Simon Fraser University, British Columbia, BC V5A 1S6, Canada
| | - S Buck
- Laura and John Arnold Foundation, Houston, TX 77056, USA
| | - R Cook-Deegan
- Consortium for Science Policy and Outcomes at Arizona State University, Washington, DC 20009, USA
| | - T Gardner
- Riffyn, Inc., Oakland, CA 94612, USA
| | - B Hanson
- American Geophysical Union, Washington, DC 20009, USA
| | - C Hustad
- Merck & Co., Inc., Kenilworth, NJ 07033, USA
| | - V Kiermer
- Public Library of Science (PLOS), San Francisco, CA 94111, USA
| | - D Lazer
- Northeastern University, Boston, MA 02115, USA
| | - A Lupia
- University of Michigan, Ann Arbor, MI 48109, USA
| | - A Manrai
- Harvard Medical School, Boston, MA 02115, USA
| | - L McConnell
- Bayer U.S., Research Triangle Park, NC 27709, USA
| | - K Noonan
- McDonnell Boehnen Hulbert & Berghoff LLP, Chicago, IL 60606, USA
| | - E Phimister
- The New England Journal of Medicine, Boston, MA 02115, USA
| | - B Simon
- Thomas Jefferson School of Law, San Diego, CA 92101, USA
| | - K Strandburg
- New York University School of Law, New York, NY 10012, USA
| | - Z Summers
- ExxonMobil Research and Engineering Company, Annandale, NJ 08801, USA
| | - D Watts
- Microsoft Research, New York, NY 10003, USA
| |
Collapse
|
4
|
Lulli M, Cammalleri M, Granucci I, Witort E, Bono S, Di Gesualdo F, Lupia A, Loffredo R, Casini G, Dal Monte M, Capaccioli S. In vitro and in vivo inhibition of proangiogenic retinal phenotype by an antisense oligonucleotide downregulating uPAR expression. Biochem Biophys Res Commun 2017; 490:977-983. [PMID: 28666875 DOI: 10.1016/j.bbrc.2017.06.150] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2017] [Accepted: 06/26/2017] [Indexed: 01/10/2023]
Abstract
Neoangiogenesis is the main pathogenic event involved in a variety of retinal diseases. It has been recently demonstrated that inhibiting the urokinase-type plasminogen activator receptor (uPAR) results in reduced angiogenesis in a mouse model of oxygen-induced retinopathy (OIR), establishing uPAR as a therapeutic target in proliferative retinopathies. Here, we evaluated in cultured human retinal endothelial cells (HRECs) and in OIR mice the potential of a specific antisense oligodeoxyribonucleotide (ASO) in blocking the synthesis of uPAR and in providing antiangiogenic effects. uPAR expression in HRECs was inhibited by lipofection with the phosphorotioated 5'-CGGCGGGTGACCCATGTG-3' ASO-uPAR, complementary to the initial translation site of uPAR mRNA. Inhibition of uPAR expression via ASO-uPAR was evaluated in HRECs by analyzing VEGF-induced tube formation and migration. In addition, the well-established and reproducible murine OIR model was used to induce retinal neovascularization in vivo. OIR mice were injected intraperitoneally with ASO-uPAR and retinopathy was evaluated considering the extent of the avascular area in the central retina and neovascular tuft formation. The ASO-uPAR specifically decreased uPAR mRNA and protein levels in HRECs and mitigated VEGF-induced tube formation and cell migration. Noteworthy, in OIR mice ASO-uPAR administration reduced both the avascular area and the formation of neovascular tufts. In conclusion, although the extrapolation of these experimental findings to the clinic is not straightforward, ASO-uPAR may be considered a potential therapeutic tool for treatment of proliferative retinal diseases.
Collapse
Affiliation(s)
- Matteo Lulli
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, viale GB Morgagni 50, 50134 Florence, Italy.
| | - Maurizio Cammalleri
- Department of Biology, University of Pisa, via San Zeno 31, 56127 Pisa, Italy
| | - Irene Granucci
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, viale GB Morgagni 50, 50134 Florence, Italy
| | - Ewa Witort
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, viale GB Morgagni 50, 50134 Florence, Italy
| | - Silvia Bono
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, viale GB Morgagni 50, 50134 Florence, Italy
| | - Federico Di Gesualdo
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, viale GB Morgagni 50, 50134 Florence, Italy
| | - Antonella Lupia
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, viale GB Morgagni 50, 50134 Florence, Italy
| | - Rosa Loffredo
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, viale GB Morgagni 50, 50134 Florence, Italy
| | - Giovanni Casini
- Department of Biology, University of Pisa, via San Zeno 31, 56127 Pisa, Italy
| | - Massimo Dal Monte
- Department of Biology, University of Pisa, via San Zeno 31, 56127 Pisa, Italy
| | - Sergio Capaccioli
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, viale GB Morgagni 50, 50134 Florence, Italy.
| |
Collapse
|
5
|
Mimmi S, Vecchio E, Iaccino E, Rossi M, Lupia A, Albano F, Chiurazzi F, Fiume G, Pisano A, Ceglia S, Pontoriero M, Golino G, Tassone P, Quinto I, Scala G, Palmieri C. Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients. Leukemia 2016; 30:2419-2422. [PMID: 27568521 PMCID: PMC5155031 DOI: 10.1038/leu.2016.245] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- S Mimmi
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - E Vecchio
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - E Iaccino
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - M Rossi
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - A Lupia
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - F Albano
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - F Chiurazzi
- Department of Clinical Medicine, University 'Federico II' of Naples, Naples, Italy
| | - G Fiume
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - A Pisano
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - S Ceglia
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - M Pontoriero
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - G Golino
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - P Tassone
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - I Quinto
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - G Scala
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| | - C Palmieri
- Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, Catanzaro, Italy
| |
Collapse
|
6
|
Nosek BA, Alter G, Banks GC, Borsboom D, Bowman SD, Breckler SJ, Buck S, Chambers CD, Chin G, Christensen G, Contestabile M, Dafoe A, Eich E, Freese J, Glennerster R, Goroff D, Green DP, Hesse B, Humphreys M, Ishiyama J, Karlan D, Kraut A, Lupia A, Mabry P, Madon TA, Malhotra N, Mayo-Wilson E, McNutt M, Miguel E, Paluck EL, Simonsohn U, Soderberg C, Spellman BA, Turitto J, VandenBos G, Vazire S, Wagenmakers EJ, Wilson R, Yarkoni T. SCIENTIFIC STANDARDS. Promoting an open research culture. Science 2015; 348:1422-5. [PMID: 26113702 DOI: 10.1126/science.aab2374] [Citation(s) in RCA: 954] [Impact Index Per Article: 106.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Affiliation(s)
- B A Nosek
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials.
| | - G Alter
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - G C Banks
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - D Borsboom
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - S D Bowman
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - S J Breckler
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - S Buck
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - C D Chambers
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - G Chin
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - G Christensen
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - M Contestabile
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - A Dafoe
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - E Eich
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - J Freese
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - R Glennerster
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - D Goroff
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - D P Green
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - B Hesse
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - M Humphreys
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - J Ishiyama
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - D Karlan
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - A Kraut
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - A Lupia
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - P Mabry
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - T A Madon
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - N Malhotra
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - E Mayo-Wilson
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - M McNutt
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - E Miguel
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - E Levy Paluck
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - U Simonsohn
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - C Soderberg
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - B A Spellman
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - J Turitto
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - G VandenBos
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - S Vazire
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - E J Wagenmakers
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - R Wilson
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| | - T Yarkoni
- Affiliations for the authors, all of whom are members of the TOP Guidelines Committee, are given in the supplementary materials
| |
Collapse
|
7
|
Lupia A, Peppicelli S, Witort E, Bianchini F, Carloni V, Pimpinelli N, Urso C, Borgognoni L, Capaccioli S, Calorini L, Lulli M. CD63 tetraspanin is a negative driver of epithelial-to-mesenchymal transition in human melanoma cells. J Invest Dermatol 2014; 134:2947-2956. [PMID: 24940653 DOI: 10.1038/jid.2014.258] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2013] [Revised: 05/19/2014] [Accepted: 05/26/2014] [Indexed: 12/14/2022]
Abstract
The CD63 tetraspanin is highly expressed in the early stages of melanoma and decreases in advanced lesions, suggesting it as a possible suppressor of tumor progression. We employed loss- and gain-of-gene-function approaches to investigate the role of CD63 in melanoma progression and acquisition of the epithelial-to-mesenchymal transition (EMT) program. We used two human melanoma cell lines derived from primary tumors and one primary human melanoma cell line isolated from a cutaneous metastasis, differing by levels of CD63 expression. CD63-silenced melanoma cells showed enhanced motility and invasiveness with downregulation of E-cadherin and upregulation of N-cadherin and Snail. In parallel experiments, transient and stable ectopic expression of CD63 resulted in a robust reduction of cell motility, invasiveness, and protease activities, which was proportional to the increase in CD63 protein level. Transfected cells overexpressing the highest level of CD63 when transplanted into immunodeficient mice showed a reduced incidence and rate of tumor growth. Moreover, these cells showed a reduction of N-cadherin, Vimentin, Zeb1, and a-SMA, and a significant resistance to undergo an EMT program both in basal condition and in the following stimulation with TGFβ. Thus, our results establish a previously unreported mechanistic link between the tetraspanin CD63 and EMT abrogation in melanoma.
Collapse
Affiliation(s)
- Antonella Lupia
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy
| | - Silvia Peppicelli
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy
| | - Ewa Witort
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy
| | - Francesca Bianchini
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy
| | - Vinicio Carloni
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
| | - Nicola Pimpinelli
- Clinical, Preventive and Oncologic Dermatology Section, Department Critical Care Medicine and Surgery, University of Florence, Florence, Italy
| | - Carmelo Urso
- Department of Anatomic Pathology, Santa Maria Annunziata Hospital, Florence, Italy
| | - Lorenzo Borgognoni
- Plastic Surgery Unit, Regional Melanoma Referral Center, Tuscan Tumor Institute (ITT), Santa Maria Annunziata Hospital, Florence, Italy
| | - Sergio Capaccioli
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy
| | - Lido Calorini
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
| | - Matteo Lulli
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
| |
Collapse
|
8
|
Martino A, Buda G, Maggini V, Lapi F, Lupia A, Di Bello D, Orciuolo E, Galimberti S, Barale R, Petrini M, Rossi AM. Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma? Leuk Res 2012; 36:594-7. [DOI: 10.1016/j.leukres.2012.02.009] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2011] [Revised: 12/27/2011] [Accepted: 02/08/2012] [Indexed: 11/30/2022]
|